Tirosina Quinase/Adaptador
Os inibidores de tirosina quinase e adaptadores são compostos que têm como alvo as tirosina quinases e suas proteínas adaptadoras associadas, que desempenham papéis fundamentais na sinalização celular, crescimento e diferenciação. Esses inibidores são ferramentas essenciais na pesquisa sobre o câncer, pois muitas tirosina quinases estão envolvidas nas vias de sinalização que impulsionam o crescimento e a metástase dos tumores. Ao inibir as tirosina quinases, esses compostos podem bloquear cascatas de sinalização críticas, oferecendo potenciais estratégias terapêuticas para vários tipos de câncer e outras doenças que envolvem sinalização celular anormal. Na CymitQuimica, oferecemos uma ampla gama de inibidores de tirosina quinase e adaptadores de alta qualidade para apoiar sua pesquisa em oncologia, biologia molecular e desenvolvimento de terapias direcionadas.
Subcategorias de "Tirosina Quinase/Adaptador"
- ALK(112 produtos)
- CSF-1R(42 produtos)
- EGFR(572 produtos)
- Receptor de Efrina(23 produtos)
- FLT(92 produtos)
- Receptor do Factor de Crescimento Fibroblasto (FGFR)(170 produtos)
- HER(5 produtos)
- Hck(3 produtos)
- IGF-1R(86 produtos)
- PDGFR(126 produtos)
- PYK2(7 produtos)
- Src(78 produtos)
- Receptor TAM(32 produtos)
- Tie-2(20 produtos)
- Receptor TrK(59 produtos)
- Tirosina Quinases(27 produtos)
- VEGFR(268 produtos)
- c-Fms(108 produtos)
- c-Kit(101 produtos)
- c-Met/HGFR(128 produtos)
- c-RET(51 produtos)
Exibir 13 mais subcategorias
Foram encontrados 1375 produtos de "Tirosina Quinase/Adaptador"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Curcumin (Natural)
CAS:Fórmula:C21H20O6Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:368.39Tyrphostin A23
CAS:Fórmula:C10H6N2O2Pureza:>98.0%(GC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:186.17Genistein
CAS:Fórmula:C15H10O5Pureza:>98.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:270.24GW 2580
CAS:Fórmula:C20H22N4O3Pureza:>98.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:366.42Tyrphostin AG 494
CAS:Fórmula:C16H12N2O3Pureza:>98.0%(HPLC)(N)Cor e Forma:Light yellow to Amber to Dark green powder to crystalPeso molecular:280.28SB 431542
CAS:Fórmula:C22H16N4O3Pureza:>97.0%(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:384.40Methyl 2,5-Dihydroxycinnamate
CAS:Fórmula:C10H10O4Pureza:>96.0%(HPLC)Cor e Forma:White to Yellow powder to crystalPeso molecular:194.19Butein
CAS:Fórmula:C15H12O5Pureza:>98.0%(HPLC)Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:272.26Dasatinib
CAS:Fórmula:C22H26ClN7O2SPureza:>95.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:488.01Tyrphostin AG528
CAS:Fórmula:C18H14N2O3Pureza:>97.0%(HPLC)Cor e Forma:Light yellow to Amber to Dark green powder to crystalPeso molecular:306.32Tyrphostin AG 490
CAS:Fórmula:C17H14N2O3Pureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:294.31Sorafenib
CAS:Fórmula:C21H16ClF3N4O3Pureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:464.83Tyrphostin AG 835
CAS:Fórmula:C18H16N2O3Pureza:>98.0%(HPLC)Cor e Forma:Light yellow to Amber to Dark green powder to crystalPeso molecular:308.34Axitinib
CAS:Fórmula:C22H18N4OSPureza:>95.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:386.47Erlotinib Hydrochloride
CAS:Fórmula:C22H23N3O4·HClPureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:429.90Gefitinib
CAS:Fórmula:C22H24ClFN4O3Pureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:446.91Piceatannol
CAS:Fórmula:C14H12O4Pureza:>98.0%(HPLC)Cor e Forma:White to Light yellow to Light red powder to crystalPeso molecular:244.25Curcumin (Synthetic)
CAS:Fórmula:C21H20O6Pureza:>97.0%(T)Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:368.39Sorafenib Tosylate
CAS:Fórmula:C21H16ClF3N4O3·C7H8O3SPureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:637.03Lapatinib
CAS:Fórmula:C29H26ClFN4O4SPureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:581.06Tyrphostin A1
CAS:Fórmula:C11H8N2OPureza:>98.0%(GC)Cor e Forma:Light orange to Yellow to Green powder to crystalPeso molecular:184.20Pelitinib
CAS:Fórmula:C24H23ClFN5O2Pureza:>97.0%(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:467.93SKLB1002
CAS:Fórmula:C13H12N4O2S2Pureza:>98.0%(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:320.39PD 153035 Hydrochloride
CAS:Fórmula:C16H14BrN3O2·HClPureza:>97.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:396.67Imatinib
CAS:Fórmula:C29H31N7OPureza:>98.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:493.62Afatinib
CAS:Fórmula:C24H25ClFN5O3Pureza:>97.0%(HPLC)(N)Cor e Forma:White to Orange to Green powder to crystalPeso molecular:485.94NVP-BHG 712
CAS:Fórmula:C26H20F3N7OPureza:>95.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:503.49RPI 1
CAS:Fórmula:C17H15NO4Pureza:>95.0%(HPLC)Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:297.31LFM-A13
CAS:Fórmula:C11H8Br2N2O2Pureza:>98.0%(HPLC)Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:360.01TCS 359
CAS:Fórmula:C18H20N2O4SPureza:>98.0%(HPLC)Cor e Forma:Light yellow to Brown powder to crystalPeso molecular:360.43JNJ-38877618
CAS:<p>JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and 3 nM for wild type and mutant Met, respectively).</p>Fórmula:C20H12F2N6Pureza:98.84% - 99.74%Cor e Forma:SolidPeso molecular:374.35Rociletinib
CAS:<p>Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic</p>Fórmula:C27H28F3N7O3Pureza:98.52% - 99.25%Cor e Forma:SolidPeso molecular:555.55FLT3-IN-3
CAS:<p>FLT3-IN-3 is an effective FLT3 inhibitor, and the IC50s of FLT3 WT and FLT3 D835Y are 13 and 8 nM, respectively.</p>Fórmula:C27H38N8OPureza:99.25%Cor e Forma:SolidPeso molecular:490.64Pyrotinib dimaleate
CAS:<p>Pyrotinib dimaleate is a selective EGFR/HER2 dual inhibitor, respectively, for the treatment of HER2-positive breast cancer.Cost-effective and quality-assured.</p>Fórmula:C40H39ClN6O11Pureza:97.27% - 99.52%Cor e Forma:SolidPeso molecular:815.22Khellin
CAS:<p>Khellin (Methafrone) is a vasodilator that also has bronchodilatory action.</p>Fórmula:C14H12O5Pureza:99.89% - 99.95%Cor e Forma:Light Yellow CrystallinePeso molecular:260.24Lucitanib
CAS:<p>Lucitanib (E-3810) is a VEGFR/FGFR inhibitor targeting VEGFR1-3 and FGFR1-2 with IC50s 7-82.5 nM.</p>Fórmula:C26H25N3O4Pureza:96.13%Cor e Forma:SolidPeso molecular:443.49Mutated EGFR-IN-1
CAS:<p>Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating</p>Fórmula:C25H31N7OPureza:98.91%Cor e Forma:SolidPeso molecular:445.56CEP-28122 mesylate salt (1022958-60-6 free base)
<p>CEP-28122 mesylate salt (1022958-60-6 free base) is a highly selective orally active ALK inhibitor (IC50: 1.9 nM in an enzyme-based TRF assay).</p>Fórmula:C29H39ClN6O6SPureza:99.79%Cor e Forma:SolidPeso molecular:635.17Mevastatin
CAS:<p>Mevastatin (ML236B) is an HMG-CoA reductase inhibitor that was initially isolated from the mold Pythium ultimum.</p>Fórmula:C23H34O5Pureza:99.12%Cor e Forma:White-Yellowish To Yellow Powder Solid PowderPeso molecular:390.51Lapatinib ditosylate monohydrate
CAS:<p>Lapatinib ditosylate monohydrate: a drug for advanced breast cancer; may cause liver issues.</p>Fórmula:C29H26ClFN4O4S·2(C7H8O3S)·H2OPureza:98% - 99.41%Cor e Forma:Colourless To Light-Yellow CrystalPeso molecular:943.47Quinoxaline, 6,7-dimethoxy-2-phenyl-
CAS:Fórmula:C16H14N2O2Pureza:98%Cor e Forma:SolidPeso molecular:266.2946Ref: IN-DA001E48
1gA consultar1mg53,00€5mg54,00€10mg73,00€25mg107,00€50mg164,00€100mg187,00€250mg503,00€AZ-Dyrk1B-33
CAS:<p>AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.</p>Fórmula:C19H16N4Pureza:99.91%Cor e Forma:SolidPeso molecular:300.36Lacnotuzumab
CAS:<p>Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, which can be used in research on retinal diseases.</p>Pureza:>95%Cor e Forma:LiquidPazopanib
CAS:<p>Pazopanib (GW786034) is an inhibitor of protein tyrosine kinases that inhibits VEGFR1/2/3. Pazopanib has antitumor activity. Cost-effective and quality-assured.</p>Fórmula:C21H23N7O2SPureza:98.78% - 99.85%Cor e Forma:White PowderPeso molecular:437.52MRX-2843
CAS:<p>MRX-2843 (UNC2371) is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).</p>Fórmula:C29H40N6OPureza:98.59% - 99.63%Cor e Forma:SolidPeso molecular:488.67CSF1R-IN-1
CAS:<p>CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.</p>Fórmula:C25H20F3N5O2Pureza:97.02% - 98.56%Cor e Forma:SolidPeso molecular:479.45Ilginatinib
CAS:<p>Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.</p>Fórmula:C21H20FN7Pureza:98.4% - 99.01%Cor e Forma:SolidPeso molecular:389.43LCH-7749944
CAS:<p>LCH-7749944 suppresses human gastric cancer cell growth, induces apoptosis, and inhibits PAK4 with IC50 of 14.93 μM.</p>Fórmula:C20H22N4O2Pureza:99.48%Cor e Forma:SolidPeso molecular:350.41Delgocitinib
CAS:<p>Delgocitinib is a potent JAK inhibitor (IC50: 2.8-58 nM), treats inflammatory diseases, and is the first topical drug for atopic dermatitis.</p>Fórmula:C16H18N6OPureza:99.95%Cor e Forma:SolidPeso molecular:310.35Tirbanibulin Mesylate
CAS:<p>Tirbanibulin Mesylate (KX01 Mesylate) is an inhibitor of Src that targets the peptide substrate site of Src (GI50: 9-60 nM in cancer cell lines).</p>Fórmula:C27H33N3O6SPureza:99%Cor e Forma:SolidPeso molecular:527.63JNJ-10198409
CAS:<p>JNJ-10198409: selective ATP competitive PDGF-RTK inhibitor; IC50: PDGFR-β 4.2 nM, PDGFR-α 45 nM; antiangiogenic & antiproliferative.</p>Fórmula:C18H16FN3O2Pureza:98.51%Cor e Forma:SolidPeso molecular:325.34Onartuzumab
CAS:<p>Onartuzumab (MetMAb) is a humanized monoclonal antibody targeting c-MET, with antitumor effects by blocking HGF and signal transduction.</p>Pureza:97.3%Cor e Forma:LiquidPeso molecular:146.99 kDaRobatumumab
CAS:<p>Robatumumab (Sch 717454) is a fully humanized anti-IGF-1R monoclonal antibody with antitumor activity and antiproliferative activity.</p>Pureza:96.9% (SDS-PAGE); 98.1% (SEC-HPLC) - 96.9% (SDS-PAGE); 98.1% (SEC-HPLC)Cor e Forma:LiquidIlginatinib maleate
CAS:<p>Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2.</p>Fórmula:C25H24FN7O4Pureza:99.74% - 99.82%Cor e Forma:SolidPeso molecular:505.5Tilvestamab
CAS:<p>Tilvestamab (BGB149) is a humanized monoclonal antibody targeting AXL with anti-tumor and anti-fibrotic activities, inhibiting Gas6-induced AXL activation.</p>Pureza:>95%Cor e Forma:LiquidLapatinib
CAS:<p>Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity.</p>Fórmula:C29H26ClFN4O4SPureza:99.00% - 99.81%Cor e Forma:PowderPeso molecular:581.06c-Met inhibitor 1
CAS:<p>c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.</p>Fórmula:C17H14N8SPureza:98.77%Cor e Forma:SolidPeso molecular:362.41ARQ 531
CAS:<p>ARQ-531: potent oral BTK inhibitor, anti-cancer potential, IC50 of 0.85/0.39 nM for WT/C481S-BTK.</p>Fórmula:C25H23ClN4O4Pureza:98.68% - 99.63%Cor e Forma:SolidPeso molecular:478.93IBT6A
CAS:<p>IBT6A is an impurity of Ibrutinib. Ibrutinib is a Btk inhibitor (IC50: 0.5 nM). IBT6A can be used in the synthesis of IBT6A Ibrutinib dimer and IBT6A adduct.</p>Fórmula:C22H22N6OPureza:99.8% - 99.88%Cor e Forma:SolidPeso molecular:386.45Bozitinib
CAS:<p>Bozitinib (PLB-1001) (PLB-1001) is a highly selective inhibitor of the c-MET kinase with blood-brain barrier permeability.</p>Fórmula:C20H15F3N8Pureza:99.16%Cor e Forma:SolidPeso molecular:424.38Rilzabrutinib
CAS:<p>Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).</p>Fórmula:C36H40FN9O3Pureza:98.28% - 99.76%Cor e Forma:SolidPeso molecular:665.76AV-412
CAS:<p>AV-412 (MP412) is an EGFR inhibitor (EGFR, EGFR T790M, EGFR L858R, EGFR L858R/T790M and ErbB2 with IC50s of 0.75, 0.79, 0.5, 2.3, 19 nM).</p>Fórmula:C41H44ClFN6O7S2Pureza:99.85% - 99.92%Cor e Forma:SolidPeso molecular:851.411-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
CAS:Fórmula:C25H23F3N4O2Pureza:98%Cor e Forma:SolidPeso molecular:468.4709Edicotinib
CAS:<p>Edicotinib (JNJ-527) is a blood-brain permeable, selective CSF-1R inhibitor, with lesser inhibitory effects on KIT and FLT3.Cost-effective and quality-assured.</p>Fórmula:C27H35N5O2Pureza:98.58% - 99.72%Cor e Forma:SolidPeso molecular:461.6TAM-IN-2
CAS:<p>TAM-IN-2 is an inhibitor of TAM.</p>Fórmula:C31H27F2N7O3Pureza:98.09% - 99.74%Cor e Forma:SolidPeso molecular:583.59Btk inhibitor 2
CAS:<p>Btk inhibitor 2 (BGB-3111 analog) is a BTK inhibitor.</p>Fórmula:C24H25N5O3Pureza:99.94%Cor e Forma:SolidPeso molecular:431.49Bucladesine sodium
CAS:<p>Bucladesine sodium (DC2797) is a cAMP analog with cell-permeable properties.</p>Fórmula:C18H23N5NaO8PPureza:96.56% - 99.76%Cor e Forma:White PowderPeso molecular:491.37Gefitinib
CAS:<p>Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations.</p>Fórmula:C22H24ClFN4O3Pureza:99.92% - >99.99%Cor e Forma:Light-Yellow Crystalline PowderPeso molecular:446.9Axatilimab
CAS:<p>Axatilimab (SNDX-6352) is a human IgG4 antibody that targets CSF-1R and can be used to study immune system diseases and respiratory diseases.</p>Pureza:97.9% (SDS-PAGE); 97% (SEC-HPLC) - 97.9% (SDS-PAGE); 97% (SEC-HPLC)Cor e Forma:LiquidBarecetamab
CAS:<p>Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity.</p>Pureza:97.1% (SDS-PAGE); 96.4% (SEC-HPLC) - 97.1% (SDS-PAGE); 96.4% (SEC-HPLC)Cor e Forma:LiquidDasatinib
CAS:<p>Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive.</p>Fórmula:C22H26ClN7O2SPureza:99.59% - 99.86%Cor e Forma:Pale-Yellow SolidPeso molecular:488.01Gancotamab
CAS:<p>Gancotamab (MM-302) is a polyethylene glycolated liposome targeting HER2 with antitumor activity for the study of advanced HER2-positive breast cancer.</p>Pureza:96.7% (SDS-PAGE); 98.4% (SEC-HPLC) - 96.7% (SDS-PAGE); 98.4% (SEC-HPLC)Cor e Forma:LiquidGIP (3-42), human
CAS:<p>Human GIP (3-42) is a peptide antagonist of GIP receptors, affecting insulin regulation and diabetes research.</p>Fórmula:C214H324N58O63SPureza:95.73%Cor e Forma:SolidPeso molecular:4749.35Intetumumab
CAS:<p>Intetumumab (CNTO 95) is a fully humanized anti-α(v)-integrin monoclonal antibody that is a radiosensitizer for xenograft tumor-bearing mice.</p>Pureza:97.6% (SDS-PAGE); 97.1% (SEC-HPLC) - 97.6% (SDS-PAGE); 97.1% (SEC-HPLC)Cor e Forma:LiquidPeso molecular:145.6 (kDa)Dasatinib monohydrate
CAS:<p>Dasatinib monohydrate, an oral SRC-kinase inhibitor, counters imatinib-resistant chronic myeloid leukemia.</p>Fórmula:C22H28ClN7O3SPureza:99.68% - >99.99%Cor e Forma:SolidPeso molecular:506.03O-Desmethyl gefitinib
CAS:<p>O-Desmethyl gefitinib is an active EGFR inhibitor (IC50: 36 nM), a metabolite of Gefitinib, formed by CYP2D6.</p>Fórmula:C21H22ClFN4O3Pureza:97.17%Cor e Forma:SolidPeso molecular:432.88Ref: IN-DA01DU9U
2mg112,00€5mg161,00€10mg156,00€25mg310,00€50mg701,00€100mgA consultar250mgA consultarMargetuximab
CAS:<p>Margetuximab (MGAH-22) is a second generation anti-HER2 monoclonal antibody with anti-tumor activity.</p>Pureza:95.3% (SDS-PAGE); 99.3% (SEC-HPLC) - 95.3% (SDS-PAGE); 99.3% (SEC-HPLC)Cor e Forma:LiquidErlotinib hydrochloride
CAS:<p>Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>Fórmula:C22H23N3O4·HClPureza:99.78% - 99.85%Cor e Forma:White Or Off-White PowderPeso molecular:429.9Bosutinib
CAS:<p>Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.</p>Fórmula:C26H29Cl2N5O3Pureza:98.98% - 99.9%Cor e Forma:Yellowish-Orange Or Pink To Brownish Solid Solid PowderPeso molecular:530.45AG 1295
CAS:<p>AG 1295 is a selective PDGFR tyrosine-kinase inhibitor; it blocks PDGFR autophosphorylation without affecting EGF receptor.</p>Fórmula:C16H14N2Pureza:99.64%Cor e Forma:SolidPeso molecular:234.3FGFR1/DDR2 inhibitor 1
CAS:<p>FGFR1/DDR2 inhibitor 1 is an inhibitor of discoindin domain receptor 2 (DDR2) and fibroblast growth factor receptor 1 (FGFR1), with IC50 values of 31.1 nM, 108</p>Fórmula:C28H22F3N5OPureza:99.43%Cor e Forma:SolidPeso molecular:501.5CSF1R-IN-2
CAS:<p>CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).</p>Fórmula:C20H20FN7O2Pureza:99.29%Cor e Forma:SolidPeso molecular:409.42Ganitumab
CAS:<p>Ganitumab (AMG 479) is a potent monoclonal antibody targeting IGF1R with 0.22 nM affinity; used in cancer research.</p>Pureza:100% (SEC-HPLC) - > 95%Cor e Forma:LiquidPeso molecular:145.70 kDaLosatuxizumab
CAS:<p>Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody with potential anti-tumor activity for the study of advanced malignant solid tumors.</p>Pureza:97.3% (SDS-PAGE); 95.1% (SEC-HPLC) - 97.3% (SDS-PAGE); 95.1% (SEC-HPLC)Cor e Forma:LiquidRilotumumab
CAS:<p>Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC and gastric cancer research.</p>Pureza:SDS-PAGE:95% SEC-HPLC:97.51%Cor e Forma:LiquidPeso molecular:145.2 kDaEmibetuzumab
CAS:<p>Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.</p>Pureza:SDS-PAGE:96.2%;SEC-HPLC:98.8%Cor e Forma:LiquidPeso molecular:143.74 kDaPetosemtamab
CAS:<p>Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR & LGR5, used in solid tumor research like HNSCC & CRC.</p>Pureza:> 95% - > 95%Cor e Forma:LiquidPeso molecular:145.97 kDaLanraplenib
CAS:<p>Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.</p>Fórmula:C23H25N9OPureza:98.35%Cor e Forma:SolidPeso molecular:443.5Erlotinib
CAS:<p>Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>Fórmula:C22H23N3O4Pureza:98.19% - 99.98%Cor e Forma:White To Off-White PowderPeso molecular:393.44Adrenalone hydrochloride
CAS:<p>Adrenalone HCl: α1-adrenoceptor agonist, topical hemostatic, vasoconstrictor, prolongs local anesthesia.</p>Fórmula:C9H11NO3·HClPureza:99.94%Cor e Forma:SolidPeso molecular:217.65Hck-IN-1
CAS:<p>Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.</p>Fórmula:C16H11ClN6O3SPureza:99.07%Cor e Forma:SolidPeso molecular:402.81Lapatinib Ditosylate
CAS:<p>Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).</p>Fórmula:C29H26ClFN4O4S·2C7H8O3SPureza:99.41%Cor e Forma:Yellow SolidPeso molecular:925.46GSK-626616
CAS:<p>GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.</p>Fórmula:C18H10Cl2N4OSPureza:98.27%Cor e Forma:SolidPeso molecular:401.27CE-245677
CAS:<p>CE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases. With a cellular IC50s of 4.7 and 1 nM.</p>Fórmula:C24H22Cl2N6O3Pureza:98.99% - 99.23%Cor e Forma:SolidPeso molecular:513.38F-1
CAS:<p>F-1: Potent ALK/ROS1 inhibitor with 2.1-3.9 nM IC50s; suppresses p-ALK signaling.</p>Fórmula:C22H27ClN8O3SPureza:97.66%Cor e Forma:SolidPeso molecular:519.02Allitinib
CAS:<p>Allitinib (AST-1306) (AST-1306) has anti-cancer activity，and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]</p>Fórmula:C24H18ClFN4O2Pureza:99.89% - 99.91%Cor e Forma:SolidPeso molecular:448.88
![1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0078T8.webp&w=3840&q=75)
